Generate Biomedicines, Inc. Research and Development Expense
Generate Biomedicines, Inc. (GENB) reported Research and Development Expense of $64.33 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- Generate Biomedicines, Inc. research and development expense for the quarter ending 2026-06-30 was $64.33M, a 7.69% increase year-over-year.
- Generate Biomedicines, Inc. research and development expense for the quarter ending 2026-03-31 was $57.81M, a 23.46% increase year-over-year.
- Generate Biomedicines, Inc. research and development expense for the quarter ending 2025-06-30 was $59.73M.
- Generate Biomedicines, Inc. research and development expense for the quarter ending 2025-03-31 was $46.83M.
| Period end | Research and Development Expense 1 month | Research and Development Expense 3 month | Research and Development Expense 6 month |
|---|---|---|---|
| 2026-06-30 | $64.33M 10-Q · filed 2026-08-06 | $122.14M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $57.81M 10-Q · filed 2026-05-07 | ||
| 2025-06-30 | $59.73M 10-Q · filed 2026-08-06 | $106.56M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $46.83M 10-Q · filed 2026-05-07 | ||
| 2021-08-31 | $10.00M 10-Q · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |